We are live on ! Find out more
VF

Virtu Financial Portfolio holdings

AUM $2.41B
1-Year Est. Return 48.35%
This Fund
S&P 500
This Quarter Est. Return
+11.53%
1 Year Est. Return
+48.35%
3 Year Est. Return
+116.81%
5 Year Est. Return
+139.6%
10 Year Est. Return
AUM
$1.41B
AUM Growth
+$485M
Cap. Flow
+$476M
Cap. Flow %
33.7%
Top 10 Hldgs %
33.91%
Holding
2,402
New
1,004
Increased
228
Reduced
294
Closed
855

Sector Composition

Rank Sector Weight
1 Financials 12.44%
2 Technology 9.83%
3 Consumer Discretionary 8.03%
4 Healthcare 7.89%
5 Communication Services 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBAR icon
1401
BBVA Argentina
BBAR
$3.36B
$63K ﹤0.01%
23,006
+12,065
+110% +$34.7K
TANH icon
1402
Tantech Holdings
TANH
$6.04M
$63K ﹤0.01%
5
+3
+150% +$49.3K
PFIE
1403
DELISTED
Profire Energy, Inc
PFIE
$63K ﹤0.01%
+57,301
New +$65.8K
AGTC
1404
DELISTED
Applied Genetic Technologies Corporation
AGTC
$63K ﹤0.01%
12,448
-36,230
-74% -$188K
SMTS
1405
DELISTED
Sierra Metals Inc. Common Stock
SMTS
$63K ﹤0.01%
20,048
-19,795
-50% -$62.3K
PXLW icon
1406
Pixelworks
PXLW
$38.3M
$62K ﹤0.01%
+1,554
New +$64.8K
XPL icon
1407
Solitario Resources
XPL
$74.8M
$62K ﹤0.01%
74,337
-40,804
-35% -$34.6K
PTE
1408
DELISTED
PolarityTE, Inc. Common Stock
PTE
$62K ﹤0.01%
2,249
+1,440
+178% +$44.6K
CIA icon
1409
Citizens
CIA
$188M
$61K ﹤0.01%
+10,511
New +$64.8K
XTKG
1410
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
ORKA
1411
Oruka Therapeutics
ORKA
$6.31B
$61K ﹤0.01%
1,388
-665
-32% -$34.9K
APM
1412
DELISTED
Aptorum Group
APM
$59K ﹤0.01%
1,982
-694
-26% -$22.3K
STEX
1413
Streamex Corp
STEX
$83M
$59K ﹤0.01%
1,375
-1,319
-49% -$61.6K
GNFT
1414
DELISTED
Genfit
GNFT
$59K ﹤0.01%
+12,872
New +$66.3K
BCTX
1415
Briacell Therapeutics
BCTX
$30M
$58K ﹤0.01%
+101
New +$54.9K
ITRG
1416
Integra Resources
ITRG
$527M
$57K ﹤0.01%
8,460
+962
+13% +$8.01K
TEF
1417
DELISTED
Telefonica
TEF
$57K ﹤0.01%
+14,090
New +$57.4K
SNPR.WS
1418
DELISTED
Tortoise Acquisition Corp. II Warrants, each whole warrant exercisable for one Class A ordinary shar
SNPR.WS
$57K ﹤0.01%
+17,474
New +$63.4K
VCNX
1419
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$56K ﹤0.01%
+89
New +$57.2K
AMPY icon
1420
Amplify Energy
AMPY
$186M
$55K ﹤0.01%
19,624
-81,238
-81% -$216K
ACER
1421
DELISTED
Acer Therapeutics Inc
ACER
$55K ﹤0.01%
+17,646
New +$60K
APRE icon
1422
Aprea Therapeutics
APRE
$8.17M
$53K ﹤0.01%
524
-677
-56% -$79K
DSX icon
1423
Diana Shipping
DSX
$294M
$53K ﹤0.01%
25,218
-23,549
-48% -$46.2K
FEED
1424
ENvue Medical Inc
FEED
$3.7M
$53K ﹤0.01%
24
+19
+380% +$48.7K
YJ
1425
Yunji
YJ
$10.9M
$53K ﹤0.01%
622
-2,041
-77% -$206K

Similar funds

Virtu Financial's Q1 2021 Portfolio in Review

As of Q1 2021, Virtu Financial held 2,402 positions worth $1.41B, up 52% from $928M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Virtu Financial deployed $476M of net new capital in Q1 2021, opening 1,004 new positions and adding to 228 existing holdings. Its largest new stake was SPDR Gold Trust: 1,328,908 shares worth $213M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 6.5% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Burgundy Technology Acquisition Corporation Unit, an estimated $12.3M trimmed.

  • Virtu Financial's largest Q1 2021 buy was SPDR Gold Trust: 1,328,908 shares worth $213M.
  • Virtu Financial added most to Alphabet (Google) Class A in Q1 2021, an estimated $15.3M increase.
  • Virtu Financial's biggest Q1 2021 reduction was Burgundy Technology Acquisition Corporation Unit, cutting an estimated $12.3M.
  • Virtu Financial fully exited Vanguard S&P 500 ETF in Q1 2021, selling an estimated $24.5M.
  • Virtu Financial's ten largest holdings make up 34% of its $1.41B portfolio in Q1 2021.
  • Virtu Financial opened 1,004 new positions and closed 855 in Q1 2021.
  • Virtu Financial's portfolio value rose 52% quarter-over-quarter to $1.41B.

Based on Virtu Financial's 13F filing for Q1 2021, filed 19 May 2021.